5 Stocks That Will Probably Make Huge Moves Next Year

TL;DR

Five heavily shorted stocks are expected to make significant moves in 2014, including Arena Pharmaceuticals, Cliff's natural resources, Soda Stream, X1, and Tesla.

Transcript

every year has its share of stocks that make outsize moves in 2014 will be no exception but what if we could know what some of these stocks would be beforehand my name is Brian stoel I'm a contributor at the mle fool and I want to talk to you quickly about five stocks that I believe are pretty much certain to make big moves in 2014 the reason for t... Read More

Key Insights

• 🎁 Heavily shorted stocks can present opportunities for significant moves.
• ❓ The success of biopharmaceutical companies often relies on insurance coverage and increasing sales.
• 🖐️ Commodity prices play a pivotal role in mining company performance.
• 🤩 Market perception and product performance during key periods can impact a company's stock valuation.
• ❓ Skepticism can arise when a company's stock price exceeds its profitability.
• ✋ Strong execution of business strategies is crucial for justifying high valuations.
• 👶 New market trends and regulatory developments can significantly impact stock performance.

Questions & Answers

Q: What key factor will determine Arena Pharmaceuticals' success in 2014?

Arena Pharmaceuticals' success in 2014 hinges on increasing sales of their weight loss drug, Bel, and securing insurance coverage for the medication.

Q: What is the primary factor that will impact Cliff's natural resources' performance in 2014?

The price of iron ore will be the key factor affecting Cliff's natural resources' success in 2014. If prices remain low or demand increases, the company's performance may be affected.

Q: Why is Soda Stream considered a risky investment by some investors?

Some investors view Soda Stream as a fad and doubt its long-term potential. The company's performance during the holiday season will be crucial in determining its success in 2014.

Q: Why are investors betting against X1 despite its increased sales?

Although X1 has experienced an 80% increase in sales, it is still not profitable. This, combined with skepticism about the 3D printing industry's stock prices, has led to investors betting against X1 in the near term.

Summary & Key Takeaways

• Arena Pharmaceuticals' weight loss drug, Bel, is the safest prescription drug but may need increased sales to perform well in 2014.

• Cliff's natural resources' success in 2014 relies on the price of iron ore.

• Soda Stream's performance during the holiday season will determine its success in 2014.

• X1, a 3D printing company, faces skepticism due to high stock prices despite increased sales.

• Tesla, the leading electric car maker, must continue executing its plan to justify its valuation of $17 billion.